Researchers in Poland recently illuminated the neuroprotective properties of GLP-1 agonists in people with mood disorders
EQQUALBERRY Vitamin Illuminating Serum This serum might look playful and cartoonish, but it means serious business
However, the weight loss induced by GLP-1R mono-therapies in obese T2DM patients is modest indicating a need for more robust therapeutic options
Epidemiology, clinical characteristics, and associations for symptom-based Rome IV functional dyspepsia in adults in the USA, Canada, and the UK: a cross-sectional population-based study
Rajvanshi is a Board-Certified Gastroenterologist, Hepatologist, and Obesity Medicine expert, who practices in the Greater Seattle area
Permanent vision damage from GLP-1 medications is extremely rare and not established in clinical trials